What is Resolve?
Resolve is a groundbreaking $225 million, 5-year global health initiative that aims to save millions of lives by reducing preventable deaths from cardiovascular disease – the world’s leading cause of death – and to prevent infectious disease epidemics. The NYC-based initiative is led by Dr. Tom Frieden, former director of the US Centers for Disease Control and Prevention, and housed within Vital Strategies, a global health organization that works in 60 countries and whose vision is to make sure everyone has access to a strong public health system. The campaign is being funded by Bloomberg Philanthropies, the Chan Zuckerberg Initiative, and the Bill and Melinda Gates Foundation.
Why is Resolve needed?
Cardiovascular disease is the world’s leading cause of death, accounting for 1 in every 3 deaths worldwide. The Ebola epidemic revealed how vulnerable the world is to health threats and was a stark reminder of the human and economic costs that can occur in the absence of strong public health systems. Both of these issues are at a tipping point. Without significant investment and attention- now - millions of preventable deaths will continue to occur and the world will not be safe from the next disease threat.
How is Resolve’s scope of work different from that of government agencies, NGOs and partner groups?
Resolve will accelerate and scale up proven strategies to reduce the burden of heart disease and stroke, and improve epidemic preparedness. High-income countries have already benefited from these programs - Resolve will now bring them to the rest of the world. Resolve brings best-in-class expertise in both cardiovascular disease and public health infrastructure, and utilizes its resources to strengthen public sector, civil society and surveillance to trigger rapid progress.
Why is Resolve housed at Vital Strategies?
Vital Strategies is ideally positioned to house this work given its strong track record in global public health – effectively managing large-scale public health initiatives that address both non-communicable disease and public health system strengthening – and its extensive global reach and relationships with ministries of health and other key partners.
Which countries will you be targeting?
We will focus on low- and middle-income countries, which is where four out of every five deaths from cardiovascular disease occur and where health systems are often less developed. More details regarding specific countries and activities will be made available as agreements are put in place.
How will you save 100M lives from cardiovascular disease?
Resolve To Save 100 Million Lives will provide assistance and strategic investment to governments and civil society in low- and middle-income countries to support the implementation of proven strategies in three policy areas that substantially reduce the burden of cardiovascular disease: eliminating trans-fat, improving treatment of high blood pressure, and reducing dietary sodium. Increasing global control of blood pressure from the current 14 percent of people with high blood pressure to 50 percent, reducing global dietary sodium intake by 30 percent and eliminating artificial trans-fat from foods would prevent more than 100 million deaths from cardiovascular disease over the next 30 years (the lifetime of people alive today with these risk factors).
What is the evidence base behind Resolve’s cardiovascular disease strategies?
There is a strong evidence base for each of these policy areas, gained from research conducted across a range of countries. View here
How will you help countries better prepare for epidemics?
Resolve To Prevent Epidemics aims to help governments in low- and middle-income countries strengthen their critical public health infrastructure, secure donor funding, and strengthen four core areas to improve capacity and preparedness, including:
● Implementing and strengthening disease tracking systems so that unusual events are promptly noticed and investigated.
● Supporting laboratory networks so that new and emerging pathogens are identified promptly.
● Training and supporting “disease detectives” – epidemiologists who will track and investigate diseases and outbreaks.
● Developing rapid response teams to investigate and stop outbreaks, working out of functional emergency operations centers operating within structured, effective incident management systems.
How will you know you’re making a difference?
We’re only implementing strategies that have been proven to work. We investigated countries that were able to effectively reduce the burden of heart disease and stroke, or improve their ability to find, stop and prevent disease threats. We plan to accelerate their programs on a global scale, saving millions of lives.
Will you be accepting money from, or working with, pharmaceutical companies?
For more information on the Vital Strategies position on working with the pharmaceutical industry, please visit: View here